Which therapy is the cornerstone of treatment for myxedema coma?

Which therapy is the cornerstone of treatment for myxedema coma?

• A. IV levothyroxine, supportive care, and hydrocortisone to avoid adrenal insufficiency
• B. IV propylthiouracil
• C. Oral levothyroxine alone
• D. Warm blankets only

Answer: (A)

In myxedema coma, the priority is rapid replacement of thyroid hormone because severe hypothyroidism disrupts virtually every organ system. The most reliable way to achieve this quickly is intravenous thyroid hormone replacement, since oral administration may be ineffective when the patient is comatose or has poor GI absorption. Hydrocortisone is added because adrenal insufficiency can accompany severe hypothyroidism or be unmasked during critical illness; giving glucocorticoids prevents precipitating an unrecognized adrenal crisis once thyroid hormone therapy begins. Alongside hormone replacement, intensive supportive care is essential: secure the airway and provide ventilation if needed, maintain blood pressure and perfusion with fluids and vasopressors as required, monitor and correct temperature, glucose, electrolytes, and organ function. That’s why the combination of IV levothyroxine, supportive care, and hydrocortisone is the best answer. IV propylthiouracil targets thyrotoxic states, not myxedema coma; oral levothyroxine alone may not be reliably absorbed in this setting; and warming blankets alone do not treat the underlying hormone deficiency.

In myxedema coma, the priority is rapid replacement of thyroid hormone because severe hypothyroidism disrupts virtually every organ system. The most reliable way to achieve this quickly is intravenous thyroid hormone replacement, since oral administration may be ineffective when the patient is comatose or has poor GI absorption. Hydrocortisone is added because adrenal insufficiency can accompany severe hypothyroidism or be unmasked during critical illness; giving glucocorticoids prevents precipitating an unrecognized adrenal crisis once thyroid hormone therapy begins. Alongside hormone replacement, intensive supportive care is essential: secure the airway and provide ventilation if needed, maintain blood pressure and perfusion with fluids and vasopressors as required, monitor and correct temperature, glucose, electrolytes, and organ function.

That’s why the combination of IV levothyroxine, supportive care, and hydrocortisone is the best answer. IV propylthiouracil targets thyrotoxic states, not myxedema coma; oral levothyroxine alone may not be reliably absorbed in this setting; and warming blankets alone do not treat the underlying hormone deficiency.